A Brief History of AP Nutripharm
AP Nutripharm Pte Ltd (APN), formed in November, 2002 is a Singapore-based biotech and fermentation company. Together with the venture capitalists, Dr Mark Xu founded the company by acquiring the former Food Biotechnology Centre in Singapore’s PSB Corporation, which assets included a bio-reactor plant and laboratory facilities, and know-how for submerged cultivation technology of Cordyceps sinensis. Acquisition gives the APN a significant competitive edge in the field of biological healthcare or therapeutic products.
There was a revolutionary movement in the Western health care world around the early 1990s; the concepts of functional foods, health supplements and alternative medicines, started to grow and challenge the “conventional” school of medicine (or Western medicine). Although the popular adage “Prevention is better than cure” is now well-accepted, at that time there was much resistance to the notion. On the other hand, the saying is well-rooted in TCM.
When studying for his masters and PhD in Australia, Dr Mark Xu was inevitably involved in that trend of development. For example, part of his PhD work was on purification of bioactive proteins, ie, immunoglobulin or antibodies that were supposed to be used in conventional medicine, but his interest was more on the functional foods and health supplements. After returning to Asia, it was logical for his to look at TCM, particularly food products with medicinal properties such as cordyceps, lingzhi, red yeast, ginseng, etc. His interest now is to develop this health care area.
We are devoted to continuously creating scientifically-proven products of medicinal fungi, lifestyle medicines, animal nutritional and cosmeceuticals, through a research-driven approach and biotechnology process, helping our customers to meet their wishes - healthy, beauty and happy life.
Our Business Activities
The business activities of AP Nutripharm Pte Ltd includes R&D, the manufacture and distribution of bulk medicinal fungal ingredients such as Cordyceps sinensis, Lingzhi etc, nutraceuticals, Chinesee proprietary medicine (CPM), health foods, health supplements, pharmaceutical ingredients, animal nutritional additives. APN is the ONLY manufacturer of Cordyceps sinensis material in the region.
You can reach us at +65 6296 8646 or via this contact form.
- Microbial cultivation process to produce cellular mass and metabolites of small compounds.
- Plant or animal cell cultivation to produce cellular mass and metabolites of small compounds.
- Application in animal farming.
- Application in skin whitening & healing.
- Human clinical trials.
- Bio-separation of pharmaceutical or nutraceutical compounds through chromatography and membrane technology.
- APN owns the worldwide patents to protect its processes and products.
Plant & Laboratory
APN is facilitated by a computer-controlled bioreactor plant together with microbiological & analytical laboratories located in Singapore Science Park I.
Research & Development (R&D)
As a research driven business, APN is commitment to continued efforts on development of new technology and products. Company is currently running the flowing research programs:
i) Development of skin lightening & healing ingredients from Cordyceps & Ganoderma cells.
ii) Purification of single drug compounds such as 3’-deoxyadenosine and Ophiocordin from Cordyceps species.
iii) Development of healthier Beef with a Cordyceps feeding system.
iv) Human clinical trials on improvement of blood lipid & liver profiles by CS-X100 Cordyceps sinensis.
Despite more studies needed, initial blood testing data on patients have suggested that CS-X100 Cordyceps sinensis can greatly reduce triglycerides, decrease SGPT/ALT & SGOT/AST, and improve the ratio of total cholesterol to HDL (good cholesterol).